drugset / Trial / NCT05960201

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

NCT05960201

Phase 2 Completed 23 enrolled Asan Medical Center
NaSingle-groupOpen-labelDiagnostic

Summary

This study aims to explore the diagnostic validity of \[18F\]FES PET/CT for the evaluation of axillary lymph node metastasis in patients with invasive lobular breast cancer having clinically suspected or confirmed axillary lymph node metastasis.

Timeline

Start
2023-08-10
Primary completion
2024-08-20
Completion
2024-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject F-18 16 Alpha-Fluoroestradiol Diagnostic / imaging agent 111 mbq Other
Subject F-18 16 Alpha-Fluoroestradiol Diagnostic / imaging agent 222 mbq Other